x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Hematologic Oncology Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.

science medicine

All Episodes

42:08

Oncology Today with Dr Neil Love: Bispecific...

Hematologic Oncology Update ·

2024/05/24

Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.

en

62:06

Year in Review: Clinical Investigator Perspectives on...

Hematologic Oncology Update ·

2024/05/14

Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease.

en

61:09

Meet The Professor: Optimizing the Management of...

Hematologic Oncology Update ·

2024/05/02

Dr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and novel treatment strategies for myelofibrosis.

en

97:16

Striving for Consensus: Current and Future Management...

Hematologic Oncology Update ·

2024/04/26

Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment approaches, and practical considerations for patients with the disease.

en

64:36

Oncology Today with Dr Neil Love: Key Presentations...

Hematologic Oncology Update ·

2024/04/24

Dr Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center in Houston discusses updated findings from ASH 2023 on management approaches for myelofibrosis and polycythemia vera.

en

95:11

Oncology Today with Dr Neil Love: Key Presentations...

Hematologic Oncology Update ·

2024/04/12

Dr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from ASH 2023 for the management of chronic lymphocytic leukemia and Richter’s syndrome.

en

60:13

Year in Review: Clinical Investigator Perspectives on...

Hematologic Oncology Update ·

2024/03/27

Dr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma.

en

60:12

Meet The Professor: Optimizing the Management of...

Hematologic Oncology Update ·

2024/03/08

Dr Stephen T Oh from Washington University School of Medicine in St Louis, Missouri, discusses current and emerging monitoring and management strategies for myelofibrosis.

en

58:01

Year in Review: Clinical Investigator Perspectives on...

Hematologic Oncology Update ·

2024/02/27

Dr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff Sharman of the US Oncology Network in Eugene, Oregon, discuss relevant datasets from 2023 on the management of chronic lymphocytic leukemia.

en

60:25

Meet The Professor: Optimizing the Management of...

Hematologic Oncology Update ·

2024/01/17

Dr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with acute myeloid leukemia and myelodysplastic syndromes.

en

61:30

Meet The Professor: Optimizing the Management of...

Hematologic Oncology Update ·

2023/11/10

Dr Gail J Roboz from Weill Cornell Medicine in New York discusses the optimal management of acute myeloid leukemia and myelodysplastic syndromes.

en

61:44

Meet The Professor: Optimizing the Management of...

Hematologic Oncology Update ·

2023/10/20

Dr Naval Daver from The University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging optimal management approaches for patients with acute myeloid leukemia and myelodysplastic syndromes.

en

61:33

What Clinicians Want to Know About the Management of...

Hematologic Oncology Update ·

2023/10/19

Dr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United Kingdom, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, discuss the management of relapsed/refractory mantle cell lymphoma.

en

79:48

Oncology Today with Dr Neil Love: Key Presentations...

Hematologic Oncology Update ·

2023/10/18

Dr Joseph Mikhael from the City of Hope Cancer Center in Phoenix, Arizona, discusses recent updates and future directions in the management of newly diagnosed and relapsed/refractory multiple myeloma.

en

46:27

Oncology Today with Dr Neil Love: Bispecific...

Hematologic Oncology Update ·

2023/10/12

Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.

en

47:30

What Clinicians Want to Know About Anti-CD38...

Hematologic Oncology Update ·

2023/10/09

Prof Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma, moderated by Dr Neil Love.

en

33:51

Oncology Today with Dr Neil Love: Blastic...

Hematologic Oncology Update ·

2023/10/05

Dr Naveen Pemmaraju from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging management approaches for blastic plasmacytoid dendritic cell neoplasms.

en

39:10

Oncology Today with Dr Neil Love: Emerging Role of...

Hematologic Oncology Update ·

2023/09/28

Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of CELMoDs and other novel approaches to targeting protein degradation pathways in the treatment of multiple myeloma.

en

62:43

What Clinicians Want to Know About Toxicity...

Hematologic Oncology Update ·

2023/09/22

Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the spectrum of toxicities associated with BTK inhibitors and strategies for their mitigation and management for patients with chronic lymphocytic leukemia and mantle cell lymphoma.

en

60:41

Inside the Issue: The Current and Future Role of CD20...

Hematologic Oncology Update ·

2023/09/14

Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.

en

601 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter